BSPM — Biostar Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Biostar Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2012 December 31st	2013 December 31st	2014 December 31st	2015 December 31st	2016 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.76	0.08	1.69	0.039	0.173
Net Total Accounts Receivable
Net Total Receivables	35.7	31.6	36.8	15.9	6.85
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	42	36	43.6	16.2	7.37
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.98	7.73	8.48	6.81	5.87
Net Intangible Assets
Other Long Term Assets
Total Assets	70.5	67.6	81.2	51.4	42.5
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	12.7	4.79	8.91	7.1	5.62
Total Long Term Debt
Total Debt
Total Liabilities	12.7	4.79	8.91	7.1	5.62
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	57.8	62.8	72.3	44.3	36.9
Total Liabilities & Shareholders' Equity	70.5	67.6	81.2	51.4	42.5
Total Common Shares Outstanding